NSE - Delayed Quote INR

Windlas Biotech Limited (WINDLAS.NS)

Compare
1,058.40 -6.95 (-0.65%)
At close: 3:29:54 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Ms. Komal Gupta CFO & CEO -- -- --
Mr. Ananta Narayan Panda Company Secretary & Compliance Officer -- -- --
Mr. Ashok Kumar Windlass Whole-Time Director 15.6M -- 1950
Mr. Hitesh Windlass MD & Executive Director 17.5M -- 1977
Mr. Manoj Kumar Windlass Joint MD & Executive Director 17.5M -- 1978
Mr. Pawan Kumar Sharma Executive Director 5.07M -- 1960
Mr. Mohammed Aslam President of Sales & Marketing -- -- --
Mr. Om Prakash Sule Site Quality Head -- -- --

Windlas Biotech Limited

705-706, Vatika Professional Point
Sector-66 Golf Course Extension Road
Gurugram, 122001
India
91 12 4282 1030 https://windlas.com
Sector: 
Healthcare
Full Time Employees: 
1,154

Description

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Corporate Governance

Windlas Biotech Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

September 17, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

LINCOLN.NS Lincoln Pharmaceuticals Limited
918.85
-2.50%
 
APLLTD.NS Alembic Pharmaceuticals Limited
1,046.00
-4.21%
 
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,840.75
+1.44%
 
KILITCH.NS Kilitch Drugs (India) Limited
323.20
-1.67%
 
RPGLIFE.BO RPG Life Sciences Limited
2,283.00
-0.92%
 
HESTERBIO.NS Hester Biosciences Limited
2,388.85
-1.74%
 
HIKAL.NS Hikal Limited
415.10
-3.16%
 
IOLCP.NS IOL Chemicals and Pharmaceuticals Limited
417.75
+3.69%
 
AKUMS.NS AKUMS DRUGS AND PHARMA L
587.05
-4.20%
 
BROOKS.NS Brooks Laboratories Limited
147.90
+2.00%